1. Home
  2. MRLN vs PLX Comparison

MRLN vs PLX Comparison

Compare MRLN & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$1.31

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.75

Market Cap

182.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MRLN
PLX
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
182.9M
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
MRLN
PLX
Price
$1.31
$2.75
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $7.92
N/A
AVG Volume (30 Days)
★ 3.6M
769.3K
Earning Date
11-15-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.27
Revenue
N/A
★ $52,744,000.00
Revenue This Year
$9.23
$55.77
Revenue Next Year
$153.29
N/A
P/E Ratio
★ N/A
$10.19
Revenue Growth
★ N/A
N/A
52 Week Low
$1.15
$1.60
52 Week High
$17.00
$3.19

Technical Indicators

Market Signals
Indicator
MRLN
PLX
Relative Strength Index (RSI) 26.91 57.33
Support Level N/A $2.59
Resistance Level $3.45 $2.85
Average True Range (ATR) 0.15 0.09
MACD 0.00 -0.01
Stochastic Oscillator 16.04 73.83

Price Performance

Historical Comparison
MRLN
PLX

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: